Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
18 Years
N/A
Female
Breast Cancer, Persistent Pain, Lymphedema, Neuropathic Pain, Neuropathy
Trial Information
Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
The aim of the study is 1) to determine pre-, intra and post surgical risk factors for
persistent pain after breast cancer treatment 2) to examine the prevalence of persistent
pain 6 and 12 months after surgery 3) provide a quantitative sensory testing (QST) profile
of the patient population, measured pre surgery, 1 week and 12 months after surgery.
Inclusion Criteria:
- Diagnosed with breast cancer
- 18 years or older
Exclusion Criteria:
- unable to give written consent
- unable to understand Danish
- Previous cosmetic surgery in the breast
- Previous surgery in ipsilateral breast
- Bilateral cancer
- Concomitant corrective surgery on contralateral side
- Pregnant
- Other disease or injury in the nervous system
- Psychiatric disease
- Alcohol or drug abuse
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Risk factors predisposing for persistent pain after breast cancer treatment
Outcome Description:
Pre-, intra- and postoperative risk factors predisposing for persistent pain
Outcome Time Frame:
12 months postoperative
Safety Issue:
Yes
Principal Investigator
Kenneth Geving Andersen, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Rigshospitalet, Denmark
Authority:
Denmark: The Danish National Committee on Biomedical Research Ethics
Study ID:
H-D-2007-0098
NCT ID:
NCT01523132
Start Date:
November 2011
Completion Date:
October 2013
Related Keywords:
- Breast Cancer
- Persistent Pain
- Lymphedema
- Neuropathic Pain
- Neuropathy
- Breast Neoplasms
- Lymphedema
- Neuralgia
Name | Location |
|---|
